1. Brodszki N, Skattum L, Bai X, Findlow H, Borrow R, Jönsson G. Immune responses following meningococcal serogroups a, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies. Vaccine. 2015;33(15):1839–45.
2. Carrington M, Marti D, Kissner T, Malasky M, Wade J, Klitz W, Barcellos L, Thomson G, Chen J, Truedsson L, Sturfelt G, Alper C, Awdeh Z, Huttley G. Microsatellite markers in complex disease: mapping of disease-associated regions within major histocompatibility complex. In: Goldstein DB, Schlötterer C, editors. Microsatellites Evolution and Application. Oxford: Oxford University Press; 1999.
3. Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol. 2000;74:61–88.
4. Gullstrand B, Mårtensson U, Sturfelt G, Bengtsson AA, Truedsson L. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol. 2009;156(2):303–11.
5. Johnson CA, Densen P, Hurford Jr RK, Colten HR. Wetsel RA. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem. 1992;267(13):9347–53.